Trial Profile
Comparative Study of Incretin System in Three Ethnic Groups With Abnormal Glucose Tolerance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Mar 2022 Status changed from recruiting to completed.
- 14 Sep 2018 New trial record